Pulmatrix (PULM) traded up 4.23 % during a 24 hours period ending at 09:59 PM Central Europe on Monday 26th. One Pulmatrix stock can currently be bought for about USD 1.44 on popular exchanges. Current supply of Pulmatrix stocks is 3.7 mn. Pulmatrix has a current market capitalization of USD 5.4 mn and approximately USD 13.3 k worth of Pulmatrix was traded on exchanges in the last 24 hours. Since last month end, Pulmatrix has traded -11.38 % down. Simple moving average of last 200 days is at USD 1.73. The highest price of past 52 weeks was recorded at USD 4.99 on 11/04/2025. 52 weeks low was at USD 1.16 on 04/13/2026.
Here is how related stocks have performed in the past 24 hours:
Ainos (AIMD) traded down -0.83 % and now trades at USD 0.78. Current market capitalisation for Ainos is USD 6.2 mn.
Enveric Biosciences (ENVB) traded down -4.11 % and now trades at USD 1.38. Enveric Biosciences has a market capitalisation of USD 6.3 mn.
Arrive Ai (ARAI) traded down -8.66 % and now trades at USD 0.11. Current market capitalisation for Arrive Ai is USD 6 mn.
Acurx (ACXP) traded down -0.44 % and now trades at USD 1.08. Current market capitalisation for Acurx is USD 6 mn.
Vector Science And Therapeut (PAIN.V) traded down -3.12 % and now trades at CAD 1.52. Vector Science And Therapeut has a market capitalisation of CAD 8.5 mn.
About Pulmatrix
Pulmatrix, Inc. is a clinical stage biotechnology company based in Lexington, United States. The company specializes in developing therapies for the treatment of chronic respiratory diseases such as cystic fibrosis, obstructive pulmonary, and idiopathic pulmonary fibrosis. Pulmatrix serves patients all over the country. You can learn more about their work and offerings by visiting their website at www.Pulmatrix.com . They are traded on the Nasdaq stock exchange.
